Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study

被引：0

作者：

Muchtar, Eli ^{[1
]}

Palladini, Giovanni ^{[2
]}

Schonland, Stefan ^{[3
]}

Dispenzieri, Angela ^{[4
]}

Wisniowski, Brendan ^{[5
]}

Merlini, Giampaolo ^{[2
,6
]}

Milani, Paolo ^{[7
,8
]}

Hegenbart, Ute ^{[9
]}

Dittrich, Tobias ^{[10
]}

Kastritis, Efstathios ^{[11
]}

Dimopoulos, Meletios Athanasios ^{[12
]}

Sanchorawala, Vaishali ^{[13
,14
]}

Szalat, Raphael E. ^{[13
,14
]}

Liedtke, Michaela ^{[15
]}

Gupta, Mani ^{[16
]}

Landau, Heather ^{[17
]}

Lentzsch, Suzanne ^{[18
]}

Hughes, Michael Sang ^{[19
]}

Cibeira Lopez, Maria Teresa ^{[20
]}

Blade, Joan ^{[21
]}

Kumar, Shaji Kunnathu ^{[22
]}

Wechalekar, Ashutosh D. ^{[23
]}

Gertz, Morie A. ^{[4
]}

机构：

[1] Mayo Clin, Rochester, MN USA

[2] Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

[3] Heidelberg Univ, Heidelberg, Germany

[4] Mayo Clin, Rochester, MN USA

[5] UCL, Royal Free Hosp Campus, Natl Amyloidosis Ctr, London, England

[6] Univ Pavia, Pavia, Italy

[7] Univ Pavia, Dept Mol Med, Pavia, Italy

[8] Fdn IRCCS Policlinico San Matteo, Pavia, Italy

[9] Univ Heidelberg Hosp, Internal Med Hematol Oncol & Rheumatol 5, Neckargemund, Germany

[10] Heidelberg Univ, Med Dept 5, Amyloidosis Ctr, Heidelberg, Germany

[11] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[12] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece

[13] Boston Univ Chobanian & Avedisian Sch Med, Sect Hematol & Med Oncol, Dept Med, Boston, MA USA

[14] Boston Med Ctr, Boston, MA USA

[15] Stanford Univ Sch Med, Div Hematol, Dept Med, Stanford, CA USA

[16] Stanford Univ, Stanford Amyloid Ctr, Stanford, CA USA

[17] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[18] Columbia Univ Med Ctr, Div Hematol & Oncol, New York, NY USA

[19] Columbia Univ Med Ctr, New York, NY USA

[20] Univ Barcelona, Barcelona, Spain

[21] Hosp Clin Barcelona, IDIBAPS, Amyloidosis & Multiple Myeloma Unit, Dept Hematol, Barcelona, Spain

[22] Mayo Clin, Div Hematol, Rochester, MN USA

[23] Univ Coll London Hosp, London, England

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-190226

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[31] Mass Spectrometry to Measure Response in Immunoglobulin Light Chain Amyloidosis (AL)
Dispenzieri, Angela
Dasari, Surendra
Arendt, Bonnie Kaye
Kohlhagen, Mindy Kohlhagen
Kourelis, Taxiarchis
Gertz, Morie A.
Kumar, Shaji K.
Rajkumar, S. Vincent
Buadi, Francis K.
Dingli, David
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Kyle, Robert A.
Muchtar, Eli
Hwa, Yi
Warsame, Rahma
Gonsalves, Wilson I.
Zeldenrust, Steven
Fonder, Amie
Hobbs, Miriam
Lust, John A.
Russell, Stephen J.
Murray, David L.
[J]. BLOOD, 2018, 132
[32] Tubular basement membrane amyloid deposition: is it an indicator of renal progression in light chain amyloidosis?
Markoth, Csilla
Bidiga, Laszlo
Varoczy, Laszlo
File, Ibolya
Balla, Jozsef
Matyus, Janos
[J]. RENAL FAILURE, 2023, 45 (01)
[33] A prospective study of nutritional status in immunoglobulin light chain amyloidosis
Sattianayagam, Prayman T.
Lane, Thirusha
Fox, Zoe
Petrie, Aviva
Gibbs, Simon D. J.
Pinney, Jennifer H.
Risom, Signe S.
Rowczenio, Dorota M.
Wechalekar, Ashutosh D.
Lachmann, Helen J.
Gilbertson, Janet A.
Hawkins, Philip N.
Gillmore, Julian D.
[J]. HAEMATOLOGICA, 2013, 98 (01) : 136 - 140
[34] Derivation and validation of a novel prognostic model for patients with light chain (AL) cardiac amyloidosis
Subramanian, M.
Ahamed, H.
Mathew, N.
Aribandi, A.
Narasimhan, C.
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 246 - 246
[35] Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis
Lilleness, Brian
Ruberg, Frederick L.
Mussinelli, Roberta
Doros, Gheorghe
Sanchorawala, Vaishali
[J]. BLOOD, 2019, 133 (03) : 215 - 223
[36] The Clinical Characteristics and Prognosis of Chinese Patients with Light-Chain Amyloidosis: A Retrospective Multicenter Analysis
He, Donghua
Guan, Fangshu
Hu, Minli
Zheng, Gaofeng
He, Jingsong
Han, Xiaoyan
Yang, Yang
Hong, Pan
Wang, Gang
Zhao, Yi
Wu, Wenjun
Cai, Zhen
[J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (03) : 444 - 453
[37] The Clinical Characteristics and Prognosis of Chinese Patients with Light-Chain Amyloidosis: A Retrospective Multicenter Analysis
Donghua He
Fangshu Guan
Minli Hu
Gaofeng Zheng
Jingsong He
Xiaoyan Han
Yang Yang
Pan Hong
Gang Wang
Yi Zhao
Wenjun Wu
Zhen Cai
[J]. Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 444 - 453
[38] The quest for validated treatment endpoints in light chain (AL) amyloidosis: composite criteria for a composite disease
Palladini, Giovanni
Milani, Paolo
[J]. LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 1793 - 1794
[39] Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis
Palladini, Giovanni
Schoenland, Stefan O.
Sanchorawala, Vaishali
Kumar, Shaji
Wechalekar, Ashutosh
Hegenbart, Ute
Milani, Paolo
Ando, Yukio
Westermark, Per
Dispenzieri, Angela
Merlini, Giampaolo
[J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2021, 28 (01): : 1 - 2
[40] INTENSIVE THERAPY IN AL AMYLOIDOSIS AND LIGHT-CHAIN DEPOSITION DISEASE - RESPONSE
LOKHORST, HM
VERDONCK, LF
[J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (07) : 553 - 553

← 1 2 3 4 5 →